← 產業報告目錄
CT/NG Testing Market Size, Share & Trends Analysis Report By Product (Assays & kits, Instruments/Analyzers), By Test Type (Laboratory, Point-of-care testing), By Technology (INAAT, PCR, Immunodiagnostics, Others), By End-User, By Region, And By Segment Forecasts, 2025-2034
出版商 InsightAce Analytic產業別 Healthcare & Life Sciences出版日期 2026-02-18頁數 180報告編號 INSIGHTACE-1eb5eb8eb0
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
報告摘要
Valued at USD 1.8 Bn as of 2024, the global CT/NG Testing Market is projected to climb to USD 4.2 Bn by 2034, reflecting a compound annual growth rate of 8.4% over the 2025–2034 period.
CT/NG Testing covers reshaping how healthcare entities approach this space.
Market momentum is underpinned by surging call for advanced solutions, favorable regulatory frameworks, and robust investment in research and development across major economies.
Segmental analysis reveals differentiated growth across product categories, applications, and geographical regions, with certain niches demonstrating above-average expansion potential.
Geographically, North America maintains a leading position owing to advanced infrastructure, high R&D expenditure, and a well-established regulatory environment. Meanwhile, Asia-Pacific is emerging as the fastest-growing region, underpinned by rapid industrialization and expanding end-user bases.
Competition in this space is characterized by active product development, strategic collaborations, and geographic expansion among both global leaders and specialized niche players.
This comprehensive research study delivers granular insights into market sizing, trend analysis, competitive benchmarking, and forward-looking projections to support strategic decision-making for industry participants and investors.
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global CT/NG Testing Market Snapshot
Chapter 4. Global CT/NG Testing Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. COVID-19 Impact Analysis
Chapter 5. Market Segmentation 1: By Product Estimates & Trend Analysis
5.1. By Product & Market Share, 2024-2034
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Product:
5.2.1. Assays & Kits
5.2.2. Instruments/Analyzers
Chapter 6. Market Segmentation 2: By Testing Type Estimates & Trend Analysis
6.1. By Product & Market Share, 2024-2034
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Testing Type:
6.2.1. Lab Tests
6.2.2. PoC Tests
Chapter 7. Market Segmentation 3: By Technology Estimates & Trend Analysis
7.1. By Product & Market Share, 2024-2034
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Technology:
7.2.1. Isothermal Nucleic Acid Amplification Technology
7.2.2. Polymerase Chain Reaction
7.2.3. Immunodiagnostics
7.2.4. Other Technologies
Chapter 8. Market Segmentation 4: By End User Estimates & Trend Analysis
8.1. By Product & Market Share, 2024-2034
8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By End User:
8.2.1. Diagnostic Laboratories
8.2.2. Hospitals & Clinics
8.2.3. Other End Users
Chapter 9. CT/NG Testing Market Segmentation 5: Regional Estimates & Trend Analysis
9.1. North America
9.1.1. North America CT/NG Testing Market revenue (US$ Million) estimates and forecasts By Product, 2021-2034
9.1.2. North America CT/NG Testing Market revenue (US$ Million) estimates and forecasts By Testing Type, 2021-2034
9.1.3. North America CT/NG Testing Market revenue (US$ Million) estimates and forecasts By Technology, 2021-2034
9.1.4. North America CT/NG Testing Market revenue (US$ Million) estimates and forecasts By, End User 2021-2034
9.1.5. North America CT/NG Testing Market revenue (US$ Million) estimates and forecasts By country, 2021-2034
9.1.5.1. U.S.
9.1.5.2. Canada
9.2. Europe
9.2.1. Europe CT/NG Testing Market revenue (US$ Million) By Product, 2021-2034
9.2.2. Europe CT/NG Testing Market revenue (US$ Million) estimates and forecasts By Testing Type, 2021-2034
9.2.3. Europe CT/NG Testing Market revenue (US$ Million) estimates and forecasts By Technology, 2021-2034
9.2.4. Europe CT/NG Testing Market revenue (US$ Million) estimates and forecasts By End User ,2021-2034
9.2.5. Europe CT/NG Testing Market revenue (US$ Million) by country, 2021-2034
9.2.5.1. Germany
9.2.5.2. Poland
9.2.5.3. France
9.2.5.4. Italy
9.2.5.5. Spain
9.2.5.6. UK
9.2.5.7. Rest of Europe
9.3. Asia Pacific
9.3.1. Asia Pacific CT/NG Testing Market revenue (US$ Million) By Product, 2021-2034
9.3.2. Asia Pacific CT/NG Testing Market revenue (US$ Million) estimates and forecasts By Testing Type, 2021-2034
9.3.3. Asia Pacific CT/NG Testing Market revenue (US$ Million) estimates and forecasts By Technology, 2021-2034
9.3.4. Asia Pacific CT/NG Testing Market revenue (US$ Million) estimates and forecasts By End User, 2021-2034
9.3.5. Asia Pacific CT/NG Testing Market revenue (US$ Million) By country, 2021-2034
9.3.5.1. China
9.3.5.2. India
9.3.5.3. Japan
9.3.5.4. Australia
9.3.5.5. Rest of Asia Pacific
9.4. Latin America
9.4.1. Latin America CT/NG Testing Market revenue (US$ Million) By Product, 2021-2034
9.4.2. Latin America CT/NG Testing Market revenue (US$ Million) estimates and forecasts By Testing Type, 2021-2034
9.4.3. Latin America CT/NG Testing Market revenue (US$ Million) estimates and forecasts By Technology, 2021-2034
9.4.4. Latin America CT/NG Testing Market revenue (US$ Million) estimates and forecasts By End User, 2021-2034
9.4.5. Latin America CT/NG Testing Market revenue (US$ Million) By country, (US$ Million) 2021-2034
9.4.5.1. Brazil
9.4.5.2. Rest of Latin America
9.5. Middle East & Africa
9.5.1. Middle East & Africa CT/NG Testing Market revenue (US$ Million) By Product, (US$ Million)
9.5.2. Middle East & Africa CT/NG Testing Market revenue (US$ Million) estimates and forecasts By Testing Type, 2021-2034
9.5.3. Middle East & Africa CT/NG Testing Market revenue (US$ Million) estimates and forecasts By Technology, 2021-2034
9.5.4. Middle East & Africa CT/NG Testing Market revenue (US$ Million) estimates and forecasts By End User, 2021-2034
9.5.5. Middle East & Africa CT/NG Testing Market revenue (US$ Million) By country, (US$ Million) 2021-2034
9.5.5.1. South Africa
9.5.5.2. GCC Countries
9.5.5.3. Rest of MEA
Chapter 10. Competitive Landscape
10.1. Major Mergers and Acquisitions/Strategic Alliances
10.2. Company Profiles
10.2.1. F. Hoffmann-La Roche Ltd. (Switzerland)
10.2.2. Hologic, Inc. (US)
10.2.3. Thermo Fisher Scientific Inc. (US)
10.2.4. Abbott Laboratories (US)
10.2.5. Bio-Rad Laboratories, Inc. (US)
10.2.6. Siemens Healthineers AG (Germany)
10.2.7. Danaher (US)
10.2.8. Becton, Dickinson and Company (US).
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理,提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們